Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Privia Health Group's accounts receivables for the quarter that ended in Jun. 2026 was $574 Mil.
Accounts receivable can be measured by Days Sales Outstanding.
Privia Health Group's Days Sales Outstanding for the quarter that ended in Jun. 2026 was 82.82.
In Ben Graham's calculation of Net-Net Working Capital, accounts receivable are only considered to be worth 75% of book value. Privia Health Group's Net-Net Working Capital per share for the quarter that ended in Jun. 2026 was $1.08.
Privia Health Group Accounts Receivable Explanation
1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.
Privia Health Group's Days Sales Outstanding for the quarter that ended in Jun. 2026 is calculated as:
2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), Privia Health Group's accounts receivable are only considered to be worth 75% of book value:
Privia Health Group's Net-Net Working Capital Per Share for the quarter that ended in Jun. 2026 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.
If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.
Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.
Privia Health Group Accounts Receivable Related Terms
Privia Health Group Accounts Receivable Historical Data
* Premium members only.
The historical data trend for Privia Health Group's Accounts Receivable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Privia Health Group (PRVA) has a Accounts Receivable of $574 Mil as of Jun. 2026. Accounts receivable is the amount a company expects to receive from credit-extending customers. View historical data on Privia Health Group and its competitors.
Is Privia Health Group's Accounts Receivable too high?
Privia Health Group's current Accounts Receivable is $574 Mil. Overall, Privia Health Group has a GF Score™ of 87/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Privia Health Group's Accounts Receivable compare to DOCS and WAY?
Privia Health Group's Accounts Receivable of $574 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Receivable for a Healthcare Providers & Services company?
A good Accounts Receivable depends on the Healthcare Providers & Services industry context. However, Accounts Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Receivable mean?
A high Accounts Receivable can signal that a stock is expensive relative to its fundamentals. Accounts receivable is the amount a company expects to receive from credit-extending customers. View historical data on Privia Health Group and its competitors. Privia Health Group's current Accounts Receivable is $574 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Privia Health Group stock overvalued right now?
Based on GuruFocus' analysis, Privia Health Group (PRVA) is currently considered Modestly Undervalued. The stock's GF Value™ is $27.55, compared to a current price of $21.07 — trading 23.5% below its estimated fair value. The current Accounts Receivable is $574 Mil. Privia Health Group's overall GF Score™ is 87/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Receivable calculated?
Accounts Receivable is calculated from a company's financial statements. For Privia Health Group (PRVA), the current Accounts Receivable is $574 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Privia Health Group (PRVA) Overvalued in 2026?
Based on GuruFocus' analysis, Privia Health Group stock appears to be undervalued.
The current stock price of $21.07 is trading 23.5% below its estimated GF Value™ of $27.55.
GuruFocus considers Privia Health Group to be Modestly Undervalued.
Key valuation signals for PRVA:
Accounts Receivable: $574 Mil
GF Value™: $27.55 vs. price of $21.07 (23.5% below fair value)
No single metric tells the full story. See the PRVA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Privia Health Group Inc is one of the physician enablement companies in the United States with a presence in around 24 states and the District of Columbia. The group builds scaled provider networks with primary-care centric medical groups, risk-bearing entities, a physician-led governance structure, and the Privia Platform comprising an extensive suite of technology and service solutions. It collaborates with medical groups, health plans, and health systems to optimize approximately 1,300+ physician practices, improve the patient experience for over 5.8+ million patients, and reward around 5,300+ physicians and practitioners for delivering high-value care.
87GF Score
Get the complete analysis for PRVA
Accounts Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PRVA has been successfully added to your 
